- 专利标题： Antimicrobial type-II bacteriocins
-
申请号： US17468311申请日： 2021-09-07
-
公开(公告)号： US12037368B2公开(公告)日： 2024-07-16
- 发明人: Nannette Y. Yount , Michael R. Yeaman
- 申请人： Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- 申请人地址： US CA Torrance
- 专利权人： Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- 当前专利权人： Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- 当前专利权人地址： US CA Torrance
- 代理机构： Sheppard Mullin Richter & Hampton LLP
- 主分类号： C07K14/32
- IPC分类号： C07K14/32 ; A61K38/16 ; A61K45/06 ; C07K14/195 ; C07K14/325 ; G16B30/10
摘要：
Computational systems and methods are described for identifying new type-II bacteriocins using a systemic consensus formula and other related criteria. Newly identified type-II bacteriocin peptides are tested experimentally and show potent microbiocidal activities.
公开/授权文献
- US20210403512A1 ANTIMICROBIAL TYPE-II BACTERIOCINS 公开/授权日：2021-12-30
信息查询
